1. Is FDC Ltd a good quality company?
Past 10 year's financial track record analysis by Moneyworks4me indicates that FDC Ltd is a good quality company.
2. Is FDC Ltd undervalued or overvalued?
The key valuation ratios of FDC Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
3. Is FDC Ltd a good buy now?
The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of FDC Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘ
Value Creation Index Colour Code Guide ⓘ
|ROCE % ⓘ||18.9%||15.1%||15.3%||16%||16.3%||13.5%||12.5%||16.1%||16.9%||11.4%||-|
|Value Creation Index ⓘ||0.4||0.1||0.1||0.2||0.2||0||-0.1||0.2||0.2||-0.2||-|
Growth Parameters ⓘ
Growth Parameters Colour Code Guide ⓘ
|YoY Gr. Rt. %||-||9.5%||4.9%||12.4%||2.2%||5.3%||1.3%||23.7%||-0.4%||14.6%||-|
|Adj EPS ⓘ||7.6||6.8||7.6||9||10.7||9.7||9.6||13.9||16.3||12.4||10.3|
|YoY Gr. Rt. %||-||-11.2%||11.8%||19.1%||18.7%||-8.9%||-1.5%||45.3%||17%||-24.1%||-|
|BVPS (₹) ⓘ||43.1||47.2||52.2||60.5||71.1||72.4||82.2||90.2||102||115.4||114.2|
|Adj Net Profit ⓘ||138||120||134||160||190||170||167||238||275||209||170|
|Cash Flow from Ops. ⓘ||149||149||127||171||153||148||104||239||210||162||-|
|Debt/CF from Ops. ⓘ||0||0||0||0||0||0||0||0||0||0||-|
CAGR Colour Code Guide ⓘ
|9 Years||5 Years||3 Years||1 Years|
|Adj EPS ⓘ||5.5%||3%||8.9%||-24.1%|
Key Financial Parameters ⓘ
Performance Ratio Colour Code Guide ⓘ
|Return on Equity % ⓘ||18.8||14.8||15.2||16||16.2||13.4||12.4||16||16.9||11.4||8.9|
|Op. Profit Mgn % ⓘ||23.9||24.3||22.5||23||24||21.2||20.5||22.2||24.5||16.3||11.9|
|Net Profit Mgn % ⓘ||18||14.4||15.3||16.2||18.8||16||15.5||17.9||20.8||13.7||10.5|
|Debt to Equity ⓘ||0||0||0||0||0||0||0||0||0||0||0|
|Working Cap Days ⓘ||99||117||112||81||157||247||271||253||289||282||203|
|Cash Conv. Cycle ⓘ||26||21||22||23||30||35||41||41||51||51||130|
Sales growth is growing at healthy rate in last 3 years 12.18%
Return on Equity has declined versus last 3 years average to 8.90%
Net Profit has been subdued in last 3 years 8.86%
Sales growth is not so good in last 4 quarters at 8.53%
|TTM EPS (₹)||10.3||10.2|
|TTM Sales (₹ Cr.)||1,617||1,622|
|BVPS (₹.) ⓘ||114.2||114.6|
|Reserves (₹ Cr.) ⓘ||1,878||1,884|
|From the Market|
|52 Week Low / High (₹)||229.15 / 319.00|
|All Time Low / High (₹)||2.44 / 404.90|
|Market Cap (₹ Cr.)||4,257|
|Equity (₹ Cr.)||16.6|
|Face Value (₹)||1|
|Industry PE ⓘ||36.3|
FDC make modest beginning in 1936, with marketing of vitamins and a range of prescription formulations. FDC set up its first formulations manufacturing facility in 1949. Subsequently, in 1963, FDC pioneered the manufacture of specialized ophthalmic formulations in India. FDC was the first organization to introduce the BFS (Blow-Fill-Seal) technology for ophthalmic in South East Asia. In 1972, FDC initiated the concept of Oral Rehydration Salts (ORS). Today its pioneer brand ‘Electral’ stands apart with a special identity- an impressive achievement in a fiercely competitive market. FDC’s API plant at Roha (Maharashtra) was among the first few API facilities in India to get US-FDA approval in 1984. Since then, FDC has to its credit a number of new molecules, introduced for the first time in the nation.
Today, FDC carries forward the flaming spirit of its first dream, achieving accreditations from the US-FDA, UK-MHRA, MCC-RSA, and the UAE, to cite a few. FDC is a forerunner in manufacturing and marketing of Oral Rehydration Salts (ORS) and Ophthalmics. FDC has also set-up globally approved, multi-location manufacturing facilities for Active Pharmaceuticals Ingredients (APIs) as well as Finished Dosage Forms. These facilities are located at Roha, Waluj and Sinnar in Maharashtra, Verna in Goa and Baddi in Himachal Pradesh. FDC markets hundreds of products in India and exports many of these to various countries.
Business area of the company
FDC Limited is among India’s leading fully integrated pharmaceutical companies. The Company is a pioneer in the manufacture of specialised formulations, and among the world’s foremost manufacturers and marketers of Oral Rehydration Salts (ORS). Over its long history of 85 years, the Company has maintained a distinguished reputation for high-quality, affordable products and built a market-leading brand portfolio.
FDC is a pioneer in the manufacture of specialized formulations, and the world's leading manufacturer of ORS (Oral Rehydration Salts) since 1972. It is a fully-integrated Pharmaceutical Company, with US-FDA and UK-MHRA approved API and formulations manufacturing facilities. FDC was the first in South East Asia to offer ophthalmic formulations, using Blow-Fill-Seal (BFS) technology.
It has its presence in numerous therapeutic segments: anti-infectives, gastrointestinals, ophthalmologicals, vitamins/ minerals/ dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, analgesics and others. FDC’s Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm are leading brands in their respective segments in India.
Products that deliver benefits consistently are the hallmark of FDC's Food Division. These products have quality certifications such as BIS (ISI mark) and HACCP. FDC has a wide range of functional foods and beverages.
Few well known brands and their use/categories are: Prosoyal for lactose intolerance; Humyl as an ideal protein supplement; Zefrich as a complete family nourisher; Enerzal, a Balanced Energy drink; and Simyl MCT, Simyl LBW and MumMum 1 and 2 as infant milk substitutes.
To develop cost-effective, environment-friendly, high-quality APIs meeting stringent ICH standards is the main focus of FDC’s API division. The company’s products and manufacturing facilities have been inspected and approved multiple times by major Regulatory bodies such as US-FDA and WHO-GMP. Till date the company has developed over twenty-three APIs of which fourteen have already been commercialized and exported across the world.